Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 December 2005, Vol. 106, No. 12, pp. 3995-4001.
Prepublished online as a Blood First Edition Paper on August 18, 2005; DOI 10.1182/blood-2004-11-4338.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-11-4338v1
106/12/3995    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, M.-T.
Right arrow Articles by Hansen, J. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, M.-T.
Right arrow Articles by Hansen, J. A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted November 15, 2004
Accepted July 28, 2005

Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation. Synergism between IL-10 genotype of patient and IL-10 receptor-{beta} genotype of donor

Ming-Tseh Lin, Barry Storer, Paul J Martin, Li-Hui Tseng, Bryan Grogan, Pei-Jer Chen, Lue P Zhao, and John A Hansen*

The Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Pathology, The Albany Medical Center, Albany, NY, USA
The Fred Hutchinson Cancer Research Center, Seattle, WA, USA
The Fred Hutchinson Cancer Research Center, Seattle, WA, USA; School of Medicine, The University of Washington, Seattle, WA, USA
Department of Medical Genetics & Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
College of Medicine, Graduate Institutes of Clinical Medicine, National Taiwan University, Taipei, Taiwan

* Corresponding author; email: jhansen{at}fhcrc.org.

We have previously shown that the IL-10/-592*A allele of the recipient is associated with less severe acute graft-versus-host disease (GVHD) and a lower risk of non-relapse mortality after hematopoietic cell transplantation (HCT) from an HLA-identical sibling. In the present study, we evaluated examined variation in the IL-10 receptor {beta} gene as a further test of the hypothesis that the IL-10 pathway regulates the risk of acute GVHD. A single nucleotide polymorphism (A/G) at cDNA position 238 of the IL-10 receptor {beta} gene (IL-10RB/c238) was genotyped in 953 HCT recipients and their HLA-identical sibling donors. IL-10/-592 and IL-10RB/c238 genotypes were tested for association with GVHD by multivariable analysis. The IL-10/-592*A allele of the recipient and IL-10RB/c238*G allele of the donor were significantly associated with a lower risk of grades III-IV acute GVHD (trend p values 0.0008 and 0.02, respectively). The donor IL-10RB/c238*G allele provided protection among patients with the IL-10/-592 A/C or A/A genotypes but not among patients with the high risk IL-10/-592 C/C genotype. These data suggest an interaction of the patient IL-10/-592 and donor IL-10RB/c238 genotypes on risk of GVHD, further supporting the hypothesis that the IL-10 pathway plays an important role in controlling the severity of acute GVHD.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
haematolHome page
G. Serafini, M. Andreani, M. Testi, M. Battarra, A. Bontadini, E. Biral, K. Fleischhauer, S. Marktel, G. Lucarelli, M. G. Roncarolo, et al.
Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia
Haematologica, October 1, 2009; 94(10): 1415 - 1426.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P.-Y. Bochud, J. W. Chien, K. A. Marr, W. M. Leisenring, A. Upton, M. Janer, S. D. Rodrigues, S. Li, J. A. Hansen, L. P. Zhao, et al.
Toll-like Receptor 4 Polymorphisms and Aspergillosis in Stem-Cell Transplantation
N. Engl. J. Med., October 23, 2008; 359(17): 1766 - 1777.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Mullally and J. Ritz
Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation
Blood, February 15, 2007; 109(4): 1355 - 1362.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Takahashi, J. Ooi, A. Tomonari, T. Konuma, N. Tsukada, M. Oiwa-Monna, K. Fukuno, M. Uchiyama, K. Takasugi, T. Iseki, et al.
Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen
Blood, February 1, 2007; 109(3): 1322 - 1330.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020